Respiratory Medicine
Volume 104, Issue 10 , Pages 1482-1489, October 2010

Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

  • C. Verkindre

      Affiliations

    • Hopital de Bethune, Beuvry, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 32 164 4139; fax: +33 32 164 6350.
    • ,
  • Y. Fukuchi

      Affiliations

    • Juntendo University, Tokyo, Japan
    • ,
  • A. Flémale

      Affiliations

    • Chirec – Parc Léopold, Service de Pneumologie, Bruxelles, Belgium
    • ,
  • A. Takeda

      Affiliations

    • Dohoku National Hospital, Hokkaido, Japan
    • ,
  • T. Overend

      Affiliations

    • Novartis Horsham Research Centre, West Sussex, UK
    • ,
  • N. Prasad

      Affiliations

    • Novartis Horsham Research Centre, West Sussex, UK
    • ,
  • M. Dolker

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Received 7 December 2009; accepted 9 April 2010. published online 14 June 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(10)00159-9

doi:10.1016/j.rmed.2010.04.006

Respiratory Medicine
Volume 104, Issue 10 , Pages 1482-1489, October 2010

Article Tools

* Image Usage & Resolution